ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

IMNM Immunome Inc

15,385
-0,365 (-2,32%)
Zuletzt aktualisiert: 20:14:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Immunome Inc IMNM NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,365 -2,32% 15,385 20:14:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
15,75 15,12 16,1799 15,75
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:00BWImmunome Appoints Kinney Horn as Chief Business Officer
25.4.202414:26BWImmunome Appoints Sandra M. Swain to Board of Directors
05.4.202414:00BWImmunome to Present Preclinical Data for IM-3050, Its Lead..
28.3.202421:02BWImmunome Reports Full Year 2023 Financial Results and..
26.3.202413:00BWImmunome Completes Acquisition of AL102, a Phase 3 Asset for..
07.3.202414:00BWImmunome to Participate in the Leerink Partners Global..
01.3.202414:00BWImmunome to Participate in the TD Cowen 44th Annual..
22.2.202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202403:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
20.2.202414:15BWImmunome Recognizes Ayala Pharmaceuticals’ Announced..
16.2.202422:05BWImmunome Announces Closing of Public Offering and Full..
14.2.202422:11EDGAR2Form 8-K - Current report
14.2.202422:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14.2.202404:38BWImmunome Announces Pricing of Public Offering of Common..
13.2.202422:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.2.202422:10EDGAR2Form 8-K - Current report
13.2.202422:05BWImmunome Announces Proposed Public Offering of Common Stock
12.2.202420:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202414:05EDGAR2Form 8-K - Current report
05.2.202414:00BWImmunome to Present at the Guggenheim Healthcare Talks 6th..
02.2.202422:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
01.2.202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202423:27EDGAR2Form 8-K - Current report
08.1.202413:05EDGAR2Form 8-K - Current report
08.1.202413:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
04.1.202423:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
04.1.202414:00BWImmunome Appoints Phil Roberts as Chief Technical Officer
03.1.202414:00BWImmunome to Present at the 42nd Annual J.P. Morgan..
02.1.202414:05EDGAR2Form 8-K - Current report
02.1.202414:00BWImmunome Appoints Carol A. Schafer to Board of Directors
29.12.202323:00EDGAR2Form 8-K - Current report
26.12.202314:35EDGAR2Form 8-K - Current report
26.12.202314:30GLOBEAtreca Announces Asset Purchase Agreement for Sale of..
16.12.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202303:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
22.11.202322:02EDGAR2Form 8-K/A - Current report: [Amend]
16.11.202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
15.11.202312:03EDGAR2Form 8-K - Current report
10.11.202314:00BWImmunome to Present at the Stifel 2023 Healthcare Conference
09.11.202322:52EDGAR2Form 8-K - Current report
09.11.202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:00BWImmunome Reports Third Quarter 2023 Financial Results
08.11.202314:30EDGAR2Form 8-K - Current report
08.11.202314:00BWImmunome Appoints Jean-Jacques Bienaimé to Board of..
31.10.202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.10.202314:00BWImmunome Appoints Bob Lechleider, M.D., as Chief Medical..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock